Guidelines or guidance for better idiopathic pulmonary fibrosis management?

Idiopathic pulmonary fibrosis (IPF) is a rare fibrotic interstitial lung disease with a relentlessly progressive course and fatal outcome. Guidelines summarizing the current evidence and providing evidence-based recommendations for the treatment of rare diseases such as IPF are important since indiv...

Descripción completa

Detalles Bibliográficos
Autor principal: Behr, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748484/
https://www.ncbi.nlm.nih.gov/pubmed/26860906
http://dx.doi.org/10.1186/s12916-016-0567-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748484/
https://www.ncbi.nlm.nih.gov/pubmed/26860906
http://dx.doi.org/10.1186/s12916-016-0567-9

Ejemplares similares